Neuroblastoma Screening (PDQ®)–Health Professional Version - National Cancer Institute (NCI)

Neuroblastoma screening, according to solid evidence, does not lead to decreased mortality and exposes infants to potential serious harms. Get detailed information about neuroblastoma and the potential benefits and harms of screening in this summary for clinicians.